Az St-Jan Brugge-Oostende A.V.

At Az St-Jan Brugge-Oostende A.V. in Brugge, the Anesthesia and Critical Care department is involved in studies that focus on urgent care, symptom control, and safer treatment strategies across anesthesia and analgesia and critical care medicine. The research includes work on infections, respiratory illness, and neurological emergencies, with many trials aiming to improve how seriously ill patients are treated and monitored.

• Evaluating safer antibiotic strategies for febrile neutropenia and serious bacterial infections
• Testing treatments for severe community-acquired pneumonia and other acute respiratory conditions
• Studying therapies intended to improve outcomes in spontaneous intracerebral haemorrhage and traumatic brain injury

This area of research reflects a strong hospital-based focus on improving emergency treatment, reducing complications, and supporting safer care for high-risk patients.

A major part of the trial portfolio at this site concerns cardiovascular diseases and thrombotic disorders. The studies look at acute coronary syndrome, coronary artery disease, atrial fibrillation, and prevention after ischemic stroke or transient ischemic attack. The goal is to better prevent serious events such as heart attack, stroke, and systemic embolism.

• Assessing new options to reduce recurrent events after myocardial infarction and coronary procedures
• Comparing approaches for stroke prevention in patients with atrial fibrillation
• Studying treatments that may lower the risk of major cardiovascular events in high-risk patients

These trials combine prevention and treatment research, with a clear emphasis on improving long-term cardiovascular safety and patient outcomes.

The site is also active in nervous system diseases, including migraine, multiple sclerosis, and early Alzheimer's disease. Research in this area aims to ease symptoms, slow disease progression, and improve daily functioning for people living with chronic neurological conditions.

• Testing preventive options for pediatric migraine and adult migraine care
• Studying treatments for progressive multiple sclerosis and relapsing multiple sclerosis
• Evaluating therapies for early Alzheimer's disease to help reduce clinical decline

Together, these studies show a broad interest in both symptom control and disease-modifying approaches in neurology.

The clinical research portfolio includes several studies in neoplasms, especially acute myeloid leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and mantle cell lymphoma. These trials are designed to improve cancer control, deepen remission, and extend survival in patients with difficult-to-treat blood cancers.

• Assessing new treatment combinations for acute myeloid leukemia and related marrow disorders
• Comparing strategies for chronic lymphocytic leukemia and lymphoma care
• Exploring ways to improve progression-free survival and treatment effectiveness in high-risk blood cancers

This research area highlights the site's experience in oncology trials that focus on both safety and meaningful disease control.

Another important theme is the study of respiratory tract diseases and serious infections, including chronic obstructive pulmonary disease, candidemia, invasive candidiasis, and virus diseases such as cytomegalovirus. The research aims to improve treatment effectiveness, prevent complications, and support better outcomes in hospitalized or vulnerable patients.

• Testing new approaches for COPD symptom control and exacerbation prevention
• Evaluating therapies for fungal bloodstream infections and other invasive infections
• Studying prevention of congenital CMV infection and related transmission risks

These studies reflect a strong focus on infection management and respiratory care within a hospital setting.

The site also participates in trials covering immune system diseases, digestive system diseases, and nutritional and metabolic diseases. Conditions under study include rheumatoid arthritis, atopic dermatitis, Crohn's disease, hepatic encephalopathy, and obesity. The purpose of this research is to improve disease control, reduce relapse, and enhance quality of life.

• Comparing therapies for rheumatoid arthritis and atopic dermatitis
• Studying ways to prevent postoperative recurrence in Crohn's disease
• Evaluating treatments for hepatic encephalopathy and metabolic-related conditions such as obesity

This mix of studies shows a broad interest in chronic inflammatory and metabolic illnesses that often require long-term management.

In addition to major disease groups, Az St-Jan Brugge-Oostende A.V. contributes to trials in more specialized fields such as eye diseases, congenital disorders, and neuromuscular disease. Examples include retinopathy of prematurity, generalized myasthenia gravis, and transthyretin-mediated amyloid cardiomyopathy. These studies often seek to refine treatment options for patients with uncommon or complex conditions.

• Assessing long-term outcomes in retinopathy of prematurity
• Evaluating new treatment options for generalized myasthenia gravis
• Studying therapies for rare and complex conditions such as ATTR cardiomyopathy

This part of the portfolio demonstrates the site's involvement in both common hospital-based research and more specialized clinical investigation.